- Lotus Pharmaceuticals, Inc. press release ( OTCPK:LTUS ): Q3 GAAP EPS of NT$7.97
- Revenue of NT$5.39B (+76.3% Y/Y).
For further details see:
Lotus Pharmaceuticals, Inc. reports Q3 resultsFor further details see:
Lotus Pharmaceuticals, Inc. reports Q3 resultsMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Lotus Pharms Inc Company Name:
LTUS Stock Symbol:
Market:
Lotus Looking at Land Development PR Newswire NORTH PORT, Fla. , May 6, 2021 /PRNewswire/ -- Lotus Pharmaceuticals, Inc (Pink Sheets: LTUS) President Georgene Rivers announced today that Lotus Pharmaceuticals, Inc. has entered into a Land Development Deal. ...
Lotus Pharmaceuticals, Inc. Current with OTC MARKETS PR Newswire NORTH PORT, Fla. , March 16, 2021 /PRNewswire/ -- Lotus Pharmaceuticals, Inc (Pink Sheets: LTUS) President Georgene Rivers announced today that Lotus Pharmaceuticals, Inc. has become curren...
New online model to engage with global partners during the pandemic TAIPEI, May 13, 2020 - (Media OutReach) - Taiwan BIO (Bio Industry Organization) together with BIO (the global Biotechnology Innovation Organization) announced May 7 that BIO Asia-Taiwan 2020 would go ahead as scheduled with...